Adults aged @-@ years , children aged @-@ months , older infants aged @-@ months , and infants aged @-@ weeks were randomly assigned ( @:@ ) with a computer-generated randomisation list ( block size of four ) to receive either @ g Vi-CRM@ or @ g Vi-polysaccharide vaccine ( or @-valent pneumococcal conjugate vaccine in children younger than @ years ) .